Express Scripts to buy WellPoint units for $4.68 billion
- Share via
Associated Press
Prescription benefit manager Express Scripts Inc. said Monday that it would buy rival NextRx from WellPoint Inc. for $4.68 billion in cash and stock.
St. Louis-based Express would leapfrog CVS Caremark Corp. to become the No. 2 pharmacy benefit manager, with a prescription volume approaching that of industry leader Medco Health Solutions Inc.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
